Skip to main
LSB
LSB logo

LSB P/E Ratio

P/E Ratio as of Jun 16, 2025: 0.15

Average0.8586
Median0.1600
Minimum0.1400
Maximum1.72
0.15
Past Month-1.46 (90.68%)
The P/E ratio for LSB is 0.15 as of Jun 16, 2025. This represents a decrease of -93.70% compared to its 12-month average P/E ratio of 2.38. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

LakeShore Biopharma Co., Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

LakeShore Biopharma Co., Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing LakeShore Biopharma Co., Ltd to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

LSB P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 2, 2025$1.070.16
May 1, 2025$1.251.87
Apr 1, 2025$2.403.58
Mar 3, 2025$2.093.12
Feb 3, 2025$2.363.52
Jan 2, 2025$3.615.39

LSB End of Year P/E Ratio

DateP/E ratioChange
20250.15-97.09%
20245.16+578.95%
20230.76

FAQs About LakeShore Biopharma Co., Ltd (LSB) P/E ratio

The latest P/E ratio of LSB is 0.15, as of Jun 16, 2025. This is calculated based on its current stock price and earnings per share (EPS).

LakeShore Biopharma Co., Ltd’s last 12-month average P/E ratio is 2.38, compared to its current P/E ratio of 0.15. This reflects a decrease of -93.70%.

LakeShore Biopharma Co., Ltd’s current P/E ratio of 0.15 is lower than its last 12-month average P/E of 2.38. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

LakeShore Biopharma Co., Ltd’s average P/E ratio over the last 3 years is 1.82. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

LakeShore Biopharma Co., Ltd’s average P/E ratio over the last 5 years is 1.09. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

LakeShore Biopharma Co., Ltd (LSB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.